Scientists at the Oklahoma Medical Research Foundation have identified two new categories of cells in the immune system. OMRF researchers Paul Kincade, Ph.D., and Rosana Pelayo, Ph.D., have chronicled this discovery in the June 1 issue of the journal Blood. The previously unknown types of cells, which Kincade and Pelayo have named Plasmacytoid dendritic cells […]
Kincade
OMRF Researcher Takes the Helm of America’s Largest Coalition of Biological Scientists
In a news conference this morning at the National Press Club, the Federation of American Societies for Experimental Biology (FASEB) welcomed Paul W. Kincade, Ph.D., as its 89th President. Kincade heads the Immunobiology and Cancer Research Program and holds the William H. and Rita Bell Chair of Biomedical Research at the Oklahoma Medical Research Foundation. […]
OMRF Scientist’s Work Chosen for Cover of Leading Journal
An article by Oklahoma Medical Research Foundation scientist Paul W. Kincade, Ph.D., has been selected to appear on the cover of the September 17 issue of Immunity, the leading journal in the field of immunology. Kincade’s article looks at the development of immune cells from the time when they first appear in embryos and compares […]
OMRF Honors Researchers and Board Member Welcomes New Board Member
Oklahoma City, April 23, 2003 – At its semiannual board meeting last night, the Oklahoma Medical Research Foundation presented the Edward L. and Thelma Gaylord Prize for Scientific Achievement to OMRF scientist Paul W. Kincade, Ph.D. Also Tuesday, OMRF honored longtime director H.E. “Gene” Rainbolt, named K. Mark Coggeshall, Ph.D., as the first holder of […]
OMRF Researchers Discover Limitin A new interferon-like substance
(OKLAHOMA CITY) — Scientists at the Oklahoma Medical Research Foundation (OMRF) have announced the discovery of a new interferon-like substance they named “limitin” because of its ability to limit tumor cell growth. Limitin is partially similar in structure to the type I interferons, naturally occurring proteins first discovered for their ability to curtail viral replication. […]
